Relative inhibitory activities of taniborbactam and xeruborbactam against KPC variants conferring reduced susceptibility or resistance to ceftazidime/avibactam, cefiderocol, and cefepime/taniborbactam.
- DOI
- 10.1128/aac.00897-26
- Published
- 2026 Nov 4
- Container
- Antimicrobial agents and chemotherapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1128/aac.00897-26,
title = {Relative inhibitory activities of taniborbactam and xeruborbactam against KPC variants conferring reduced susceptibility or resistance to ceftazidime/avibactam, cefiderocol, and cefepime/taniborbactam.},
author = {Rodríguez-Pallares S and Le Terrier C and Blanco-Martín T and Rilo-Antelo R and Elías-López C and Sánchez-Peña L and Molina-Cáceres C and Pérez-Rodríguez G and González-Pinto L and Martínez-Martínez L and Poirel L and Bou G and Arca-Suárez J},
year = {2026},
journal = {Antimicrobial agents and chemotherapy},
doi = {10.1128/aac.00897-26},
url = {https://doi.org/10.1128/aac.00897-26}
}RIS
TY - JOUR TI - Relative inhibitory activities of taniborbactam and xeruborbactam against KPC variants conferring reduced susceptibility or resistance to ceftazidime/avibactam, cefiderocol, and cefepime/taniborbactam. AU - Rodríguez-Pallares S AU - Le Terrier C AU - Blanco-Martín T AU - Rilo-Antelo R AU - Elías-López C AU - Sánchez-Peña L AU - Molina-Cáceres C AU - Pérez-Rodríguez G AU - González-Pinto L AU - Martínez-Martínez L AU - Poirel L AU - Bou G AU - Arca-Suárez J PY - 2026 JO - Antimicrobial agents and chemotherapy DO - 10.1128/aac.00897-26 UR - https://doi.org/10.1128/aac.00897-26 ER -
APA
S, R., C, L. T., T, B., R, R., C, E., L, S., C, M., G, P., L, G., L, M., L, P., G, B., & J, A. (2026). Relative inhibitory activities of taniborbactam and xeruborbactam against KPC variants conferring reduced susceptibility or resistance to ceftazidime/avibactam, cefiderocol, and cefepime/taniborbactam.. Antimicrobial agents and chemotherapy. https://doi.org/10.1128/aac.00897-26
Source records
- pubmed · retrieved 2026-11-10T20:36:50.917Z